Liminatus Pharma LIMN
NASDAQ LIMN
$3.90 +0.15 (+4.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Liminatus Pharma (LIMN) Change in Account Payables (2024 - 2026)

Updated

Liminatus Pharma (LIMN) reported Change in Account Payables of $6,844 for Q2 2026, compared with -$83,500 a year earlier.

Analysis

Liminatus Pharma (LIMN) Change in Account Payables (2024 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Liminatus Pharma's Change in Account Payables came in at $30,878; for FY2025, it was -$62,467.

  • Five-year quarterly Change in Account Payables spans a low of -$83,500 in Q2 2025 and a high of $31,533 in Q4 2025.
  • Per Business Quant data, the three quarters before Q2 2026 came in at -$14,999 (Q1 2026), $31,533 (Q4 2025) and $7,500 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Payables (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn -
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn -
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn -
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn -
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn -
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn -
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn -70.00 Mn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 18.00 Mn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn -
10 Liminatus Pharma 4.24 Mn 4.24 Mn - 6,844.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 6,844.00
Mar 31, 2026 -14,999.00
Dec 31, 2025 31,533.00
Sep 30, 2025 7,500.00
Jun 30, 2025 -83,500.00
Mar 31, 2025 -18,000.00
Sep 30, 2024 -2,000.00
API Access

Liminatus Pharma Change in Account Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-account-payables&ticker=LIMN&period=max&api_key=YOUR_API_KEY